Exciting new findings indicate that GLP-1 weight-loss medications might dramatically reduce the likelihood of 10 types of ...

Retatrutide, a new experimental weight-loss drug, targets three hormones and shows promising results far beyond current ...

By taking into account a patient’s unique biology, psychology, environment and behaviors, Hims & Hers is able to offer access ...

“Early intervention would be lifestyle change, and that can be extremely helpful, especially in younger adolescents who are ...

A redesigned Weight Watchers experience pairs comprehensive GLP-1 support with personalised nutrition, coaching, community support, and cutting-edge technology to help members meet their weight loss g ...

WW International ( WW ), more commonly known as Weight Watchers, is fully embracing the popularity of GLP-1s and their impact ...

People on weight loss medications are being warned not to follow the latest microdosing trend which has been gaining ...

Eli Lilly is leading the market for GLP-1 medications (for weight loss and diabetes). In a decade, Eli Lilly could be in the ...

For more than two years it had the entirety of the market for weight-loss drugs to itself. By 2023 sales of Wegovy had ...

From shifting grocery habits to new product opportunities, Circana’s insights reveal how brands and retailers can adapt to ...

Thousands of low-income Pennsylvanians will face new barriers to weight-loss drugs like Ozempic under a move quietly ...

As Americans prepare for Christmas, it’s safe to say there were plenty of jokes at family tables this year about the ...